|
|||||
|
|
Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy |
|
| Authors: | Goro Kasuya MD PhD Hitoshi Ishikawa MD PhD Hiroshi Tsuji MD PhD Takuma Nomiya MD PhD Hirokazu Makishima MD PhD Tadashi Kamada MD PhD Koichiro Akakura MD PhD Hiroyoshi Suzuki MD PhD Jun Shimazaki MD PhD Yasuo Haruyama MD PhD Gen Kobashi MD PhD Hirohiko Tsujii MD PhD for the Working Group for Genitourinary Tumors |
| Affiliation: | 1. Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan;2. Department of Radiation Oncology, Graduate School of Medicine, Tsukuba University Faculty of Medicine, Ibaraki, Japan;3. Kanagawa Cancer Center, Yokohama, Japan;4. Department of Urology, Japan Community Health Care Organization Tokyo Shinjuku Medical Center, Tokyo, Japan;5. Department of Urology, Toho University Sakura Medical Center, Chiba, Japan;6. Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan;7. Department of Public Health, Dokkyo Medical University School of Medicine, Tochigi, Japan |
| Abstract: | |
| Keywords: | biochemical recurrence carbon‐ion radiotherapy high‐risk prostate cancer mortality Phoenix definition prostate‐specific antigen (PSA) prostate‐specific antigen failure |